Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
DBL Zoledronic Acid IV Infusion Zoledronic acid monohydrate 4.3mg equivalent to zoledronic acid 4mg Solution for infusion Pfizer New Zealand Limited Laboratorios Grifols S.A, Barcelona, Spain
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Imatinib-Teva Imatinib mesilate 119.469mg equivalent to imatinib 100mg Film coated tablet Teva Pharma (New Zealand) Limited PLIVA Croatia Limited, Zagreb, Croatia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Imatinib-Teva Imatinib mesilate 477.877mg equivalent to imatinib 400mg Film coated tablet Teva Pharma (New Zealand) Limited PLIVA Croatia Limited, Zagreb, Croatia
|
Dated this 3rd day of April 2018.
ALISON COSSAR, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).